Searchable abstracts of presentations at key conferences in endocrinology

ea0062oc6 | Oral Communications | EU2019

Effective novel therapy in the use of managing refractory hypoglycaemia in a patient with metastatic insulinoma

Anandappa Samantha , McGowan Barbara , Prachalias Andreas , Sarker Debashis , Miquel Rosa , Carroll Paul , Velusamy Anand

Case history: 22 year old female presented with left sided hemiparesis following a generalised seizure; the blood glucose was 1.2 mmol/l. Corrective treatment restored cerebral function. In the preceding 6 months, she had symptoms of drowsiness on waking which corrected with sugary drinks and described tiredness with lethargy. There had been no reported change in appetite or bowel habits however, there had been a degree of weight loss during this period. During hospital admiss...

ea0072p14 | (1) | UKINETS2020

Effective multimodality therapy for a metastatic insulin-secreting pancreatic neuroendocrine tumour (NET): A case report

Ting Jonathan , Kapiris Matthaios , Prachalias Andreas , Velusamy Anand , McGowan Barbara , Carroll Paul , Miquel Rosa , Thillai Kiruthikah , Sarker Debashis

A 23-year-old woman presented in May 2018 with acute left-sided hemiparesis following increasingly frequent episodes of morning drowsiness with associated weight loss. She had no significant past medical history or family history. Brain imaging excluded intracranial pathology. Blood tests during a spontaneous hypoglycaemic episode (1.5 mmol/l) identified significant hyperinsulinaemic hypoglycaemia [insulin 392 pmol/l (18–173) and C-peptide 3913 pmol/l (370–1470)]. MR...

ea0068oc2 | Abstracts | UKINETS2019

Development of ex-vivo models of metastatic neuroendocrine neoplasms

Doornebal Ewald , Harris Nicola , Edwards Helen , Miquel Rosa , Zen Yoh , Pizanias Michail , Prachalias Andreas , Menon Krishna , Zamalloa Ane , Preziosi Melissa , Heaton Nigel , Ramage John K , Williams Roger , Palma Elena , Chokshi Shilpa , Srirajaskanthan Raj

Background: The lack of relevant in-vivo and in-vitro models has precluded investigations of the pathophysiology of metastatic NENs. Organotypic tumour slices retain the complexity of tumours in-vivo without extensive manipulation of the tissue. The aims of this study are to understand the utility of precision cut slice technology to develop an immunocompetent model of metastatic GEP NENs to test new therapeutics and elucidate immunological, molecula...